Agios Pharmaceuticals Salary

Agios Pharmaceuticals average salary is $90,000, median salary is $90,000 with a salary range from $90,000 to $90,000.
Agios Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Agios Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.

Low: 90,000

Average: 90,000

Median: 90,000

High: 90,000

Agios Pharmaceuticals Jobs

Job Title	Salaries	City	Year	More Info
Other	90,000-90,000	Cambridge, MA, 02138	2009	Agios Pharmaceuticals Other Salaries (1) Agios Pharmaceuticals Cambridge, MA Salaries

Agios Pharmaceuticals Jobs

Today’s New Jobs Immediate job opening
Only $100K+ Jobs Require free registration. Manager, Director, VP, C-level Jobs

Calculate how much you could earn

It's FREE. Based on your input and our analysis. How we do it?

All fields are required for calculation accuracy.

Employer
Job Title
City
Experience
Email
We will send you an email to access your personalized report.
We won’t share your email address

Recent Agios Pharmaceuticals Salaries (May 17, 2012)

Computer Programmer	International Technology Solutions	$50,000	Chattanooga, TN, 37401	06/07/2010
Senior Chemical Engineer	Cargill	$90,000	Hopkins, MN, 55305	09/15/2010

Agios Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List

8.5 million company & government reported salaries with date & location
Salary calculator rank & calculate your salary
151 million W-2s pay scale statistics in U.S.

Related Agios Pharmaceuticals Salary

Agios Pharmaceuticals Information

Agios Pharmaceuticals
Industry: BioTech/Drugs
City: Cambridge, MA
Agios is the first biopharmaceutical company dedicated to drug discovery based on targeting cancer metabolism, which offers the potential for a new class of oncology therapeutics targeting metabolic pathways critical to cancer cell growth, proliferation and survival.
Agios Pharmaceuticals Profile
David Schenkein